South San Francisco, CA, United States of America

Harjeet Singh Ganda

This inventor holds 1 USPTO granted patent. Top assignee: Five Prime Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harjeet Singh Ganda. Retrieved from https://idiyas.com/inventor/harjeet-singh-ganda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harjeet Singh Ganda: Innovator in Antibody Formulations

Introduction

Harjeet Singh Ganda is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of antibody formulations.

Latest Patents

Ganda holds a patent for B7-H4 antibody formulations. This patent provides pharmaceutical compositions comprising antibodies and antigen-binding fragments that specifically bind to human B7-H4, and optionally to cynomolgus monkey, mouse, and/or rat B7-H4. The disclosure also includes methods for treating disorders, such as cancer, by administering these pharmaceutical compositions. He has 1 patent to his name.

Career Highlights

Harjeet Singh Ganda is currently employed at Five Prime Therapeutics, Inc., where he continues to advance his research and development efforts in the field of biotechnology. His work focuses on innovative solutions for complex medical challenges.

Collaborations

Some of his notable coworkers include Yong Quan and Chin-Yi Huang, who contribute to the collaborative environment at Five Prime Therapeutics, Inc.

Conclusion

Harjeet Singh Ganda's work in antibody formulations represents a significant advancement in the treatment of cancer and other disorders. His contributions to the field are invaluable and highlight the importance of innovation in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…